|
Speaker Biographies (Updated 5/8/06)
Dorothy H. Air
Dorothy H. Air, PhD is Associate Senior Vice President for Entrepreneurial
Affairs at the University of Cincinnati. Her primary responsibilities include
assisting faculty in start-up company activity related to new technology
development; developing a network of commercialization/business resources
for the university; and developing entrepreneurial programs to promote
entrepreneurship in the university and community. Her accomplishments include:
PI on a recently funded Pre-seed Fund grant by ODOD Third Frontier Program
for $1.1 million; PI on a $600,000 NSF Grant, Cincinnati Creates Companies,
which includes an educational and mentoring program for entrepreneurs and
a business plan competition; and Senior Investigator on a $27 million grant
from ODOD Third Frontier to establish the Center for Computational Medicine.
She is a co-founder of SoundingBoard and serves
on the Board of Directors of BIO/START and the Greater Cincinnati Venture
Association. In 2005, she was appointed as a loaned executive from the
University of Cincinnati to serve as Director of CincyTechUSA for
part of her time. Her responsibilities include developing entrepreneurial
resources and working with technology companies to develop and grow their
businesses. Dr. Air was the initiator of OVALS and has served as the chair
of the effort for the last four year.
Michael Albert
Michael Albert is a shareholder
at Wolf, Greenfield & Sacks, P.C., an intellectual property law firm
of over 60 professionals located in Boston, Massachusetts. Michael serves
as Chair of the firm’s Litigation Practice Group
and Internet Practice Group and is a member of the Trademark and Copyright
Group.
Michael’s practice is focused on the areas of trademark, copyright,
patent, and trade secret litigation. His clients include high-tech companies
in the software, Internet, biotechnology and engineering industries, as
well as consumer and retail businesses.
Michael serves as an arbitrator for Internet domain name disputes
through the World Intellectual Property Association, and is on the National
Arbitration Forum's roster of mediators and arbitrators. He also has trial
experience before state and federal courts and appellate experience before
the U.S. Courts of Appeals for the First Circuit and Federal Circuit and
the Massachusetts Supreme Judicial Court.
Michael is fluent in French and has provided legal advice to French
companies and government agencies. He teaches, speaks and writes frequently
on trademark and Internet law, and has been named in Boston Magazine as
one of Massachusetts' "Super Lawyers"
in the field of patent litigation.
Heidi Hu Ames
As the founder of Myland USA, Heidi has provided the leadership that has guided Myland USA
through a dynamic and continually evolving business environment. In the early
1990s, many companies were hesitant to consider manufacturers in China as
potential suppliers for high precision components and products. Guided by
determination and perseverance, along with a deep understanding of the business
benefits that its clients could derive from sourcing in China, Heidi successfully
nurtured the growth and development of Myland. Today, Myland's clients
speak with admiration for her business sense, attention to detail, and integrity
in serving their needs. She is fluent in Chinese, and is recognized in the
U.S. community she now calls home, as an authority on China and in Doing
Business in China.
Throughout Heidi's professional career, she has been a U.S. / Chinese
Liaison with dozens of licensed products and intellectual properties. Heidi
has personally handled and also provided guidance to the clients the process
to identify and qualify licensees, negotiate license agreements, cultivated
long term relationships, assessed and brought justice to the violating party
in China by using her knowledge of the regulations and culture, skills in
negotiation and problem-solving, connections with government and legal service
channels.
Heidi, once a University Professor, Public Relations Officer, Mediator,
Negotiator, Training Instructor, but mostly known as the China expert and
a pioneer in trading with China, continues to lead Myland USA
to assist companies with their sourcing, operations development, and market
development activities in China.
Heidi is to share the insights of How to Protect Your Intellectual
Properties in China
Jack M.
Anthony
Jack Anthony has over 30 years experience in a variety of marketing and business
roles in the pharmaceutical industry. Prior to becoming CEO of Pharmix, Jack was Senior Vice President of Saegis Pharmaceuticals, and before that Jack served as Senior
Vice President of Business and Commercial Development at Tularik Inc. where he oversaw the company's business development
initiatives and ultimate merger with Amgen. In the 13 years prior to Tularik,
Mr. Anthony held senior level business development and marketing positions
at FibroGen, Inc., Cell Therapeutics, Inc., Nektar and
Applied Immune Sciences, Inc., completing numerous research, development
and commercialization agreements with global pharmaceutical and life
sciences companies. Mr. Anthony began his healthcare career at Baxter
Healthcare in sales and marketing. Progressing through a number of domestic
and international positions over eighteen years, Mr. Anthony departed
Baxter as a vice president of the Blood Therapy Group. Mr. Anthony has
a BS in Biology from Allegheny College and was a lieutenant in the U.S.
Navy, which sponsored his graduate work at the University of Maryland
in communications. He received the Licensing Executive Society's Frank
Barnes Mentor Award in 2002 and has co-chaired a number of LES Committees.
He is currently Co-Chair of the BIO Business Development Committee and
is Chairperson of the Bay Area Biotech Business Roundtable.
Vernon Anthony
Joined
Telcordia Technologies in 1998 as Executive Director, Intellectual Capital
Products (ICP). Mr.
Anthony is primarily responsible for leading the ICP organization to
generate revenues from commercializing Telcordia’s intellectual
property assets. Previously,
he was a Division Manager in the Intellectual Property Business organization
at Lucent Technologies and AT&T from 1987 to 1998. From
1977 to 1986, Mr. Anthony was a Development
Engineer and Product Manager at AT&T. Mr.
Anthony has a BS Electrical Engineering degree from Cornell University, and
a MS Engineering Management degree from Northeastern University. He has been
a member of the Licensing Executive Society (LES) since 1987.
Imma Barrera
Dr. Imma Barrera
is the Director of Business Development at Xenogen Biosciences
where she is responsible for corporate strategic and business planning
and new technology development, including the technology assessment, valuation
and licensing of new technologies and identifying and evaluating corporate
partnering opportunities supporting the long term goals of Xenogen Biosciences.
Before joining Xenogen, Dr. Barrera was involved in academic technology
transfer programs where she managed all aspects of commercialization of
biomedical technologies from the initial evaluation of the disclosures
to license agreements. She held positions of increasing responsibilities
at the University of Minnesota, Rutgers University and Mount Sinai School
of Medicine, She holds a Ph.D. in Molecular Biology from the University
of Zurich, and has over 12 years of research experience in the field of
molecular biology/virology including work for GlaxoSmithKline in the area
of target validation, assay development and mechanism of action studies
for drug discovery programs.
She is an active member of several committees
within Licensing Executive Society (LES) and the Association of University
Technology Managers (AUTM).
Ilan Barzilay
Ilan Barzilay is an associate in Wolf Greenfield’s Litigation
Practice Group and litigates a wide variety of intellectual property cases.
He was part of the Wolf Greenfield team which successfully defended Bridgewater
Candle Company in a trade dress and copyright litigation, eventually securing
an attorneys fee award of over one million dollars for the prevailing defendant.Ilan
is also a member of the Electrical and Computer Technologies Practice Group
where he provides patent prosecution and IP counseling services to clients
in the electrical, software and internet industries.
In addition to coordinating the firm's summer
associate program, Ilan performs in the occasional
community theater/chorus production and coaches the Wellesley College mock
trial team.
Michael Batalia
Dr. Michael Batalia directs the Office of Technology
Asset Management. OTAM is responsible for managing technology development
and technology transfer for all of Wake Forest University. Prior to joining
Wake Forest University Health Sciences, Dr. Batalia was
on the staff of the Office of Technology Transfer at North Carolina State
University. In his four years at NC State, Dr. Batalia served
as the interim associate vice chancellor and director of the office and previously
as associate director. His responsibilities included managing inventions
and technology from the life sciences and physical sciences. He has worked
with many start-up companies and businesses to license intellectual property
into the commercial sector. Currently, Dr. Batalia serves
on the board of directors for several WFU start-up companies and represents
WFU’s investments
in two local angel investment funds. Dr. Batalia is
active in the Association of University Technology Managers, and he has served
on the AUTM Board of Trustees as Vice President for the Eastern Region. In
addition, Dr. Batalia is a senior associate of
MIHR, the Centre for the Management of Intellectual Property in Health Research
and Development. He currently is working with MIHR on the Africa programme
for health innovation: technology management capacity for sub-Saharan Africa. Before
joining NC State, Dr. Batalia was a postdoctoral fellow at the Lineberger
Comprehensive Cancer Center at the University of North Carolina at Chapel
Hill where his research focused on molecular immunology and structural biology.
Dr. Batalia has a B. A. in Chemistry from the University of Chicago and a
Ph.D. in Biochemistry from the University of Texas at Austin.
Sarah Bauer
Sarah Bauer currently leads
the marketing and outreach efforts for the U.S. EPA’s Federal Technology
Transfer Act Program within EPA’s Office of Research and Development (ORD). In
this position she manages a variety of outreach efforts involving Cooperative
Research and Development Agreements (CRADAs), patents, and licensing opportunities. Sarah held
two previous positions in ORD: as the Communications Director for the
Office of Science Policy, and the Outreach Coordinator for the Environmental
Technology Verification Program.
Prior to joining ORD, Sarah
was involved in multiple efforts under the Oil Pollution Act, the Clean
Air Act Amendments, and the Superfund Amendments and Reauthorization Act
in EPA’s Office of Solid Waste and Emergency Response. Additionally, Sarah
has worked as a consultant and corporate trainer in private industry.
Sarah is married and has four
children. Her main interest is spending time with her family, and in her
spare time she enjoys yoga, running, and oil painting. She has also served
on many civic committees, and currently is a member of the Capitol Hill
Arts Workshop Board of Directors, where she held the positions of Vice
President and President.
Sarah has a Bachelor's degree
in Speech Pathology and Communications.
Mark Bloom
Mr. Mark Bloom is Senior Counsel with Life Sciences Law,
PLLC, in Chapel Hill, NC.
Mark was formerly Associate General Counsel
and Chief IP Counsel of The Cleveland Clinic Foundation (CCF). Mark received a BS from The Ohio State University, a JD
from Franklin Pierce Law Center, is a member of numerous state bars, courts,
and professional organizations, and is a Registered Patent Attorney.
Before attending law school, Mark worked
in sales and marketing for the pharmaceutical and medical device industries.
Prior to joining CCF, Mark was employed as
a Licensing Associate for the Wisconsin Alumni Research Foundation.
Mark is currently a member of the Editorial
Advisory Board of the AUTM Journal and the Editorial Board of the AIPLA
Quarterly Journal. Mark also serves as a member of the “Expert Group
on Best Practice Guidelines for the Licensing of Genetic Inventions” for
the OECD.
Ben Bonifant
Ben Bonifant is an experienced
consultant to leaders of global pharmaceuticals and biotechnology organizations
and to decision makers of large private equity funds. Mr. Bonifant has been
a management consultant for more than fourteen years. His perspectives on
developments in the life-sciences market are frequently published in industry
and strategy journals. Recent by-lined
articles have appeared in Pharmaceutical Executive, Chemical Specialties,
and Business Horizons. He is the author of the chapter, “Market
Segmentation and New Product Development,” in the recent update to The PDMA
Handbook of New Product Development. In addition, Mr. Bonifant has written
case studies on the pharmaceutical industry used in graduate business programs. .Mr.
Bonifant earned an MBA from the Stanford Graduate School of Business and
a BS from Duke University.
Daryl Boudreaux
Daryl Boudreaux is a Partner in NanoHoldings LLC, an early stage innovation commercialization
and investment company. Prior to that he established and led the technology
transfer office at Rice University in Houston, TX and grew it rapidly to
parity with similar universities. He started 13 new companies there is
6 years, 9 based on Rice nanotechnology inventions. He was responsible
for assessment and commercialization of technologies that grew from university
research programs and for negotiating all intellectual property and business
development matters for the university. Prior to Rice, Daryl established
and led the Office of Technology Transfer for the Stevens Institute of
Technology in Hoboken, NJ, where he was also Director of Corporate Development.
Previously Daryl had a highly
successful 25 year career at AlliedSignal, where he was a senior
executive in the corporate RD&E organization. He led engineering development
and information technology groups whose objectives served the company’s
business units as well as external licensees. He began his career at AlliedSignal
as a physicist, initially carrying-out research as well in materials science
and chemistry. Prior to that he was Assoc. Prof of Physics at the Polytechnic
University of New York and was a postdoctoral Research Associate at the
Cavendish Laboratory of Cambridge University in the UK. He earned his PhD
in Physics from the Pennsylvania State University. He is a native of New
Orleans where he earned his BS-Physics at Loyola University.
James Bourdeau
James Bourdeau concentrates
on business law matters related to the formation, financing, expansion
and dissolution of corporations and limited liability companies. He is
experienced in mergers and acquisitions, securities offerings, venture
financing, secured transactions, and technology licensing.
Prior
to earning his law degree, Mr. Bourdeau studied
analogue and digital communications and was first employed as an electrical
engineer responsible for maintaining and expanding a broadband computer
network for an aerospace company. Later he was employed as an applications
engineer responsible for supporting a color printer sales team. His prior
experiences included computer networking, programming color printer device
drivers, and lecturing at industry trade shows and user group meetings
on color-matching techniques.
Education
Syracuse
University College of Law, J.D., summa cum laude (1995)
Clarkson University, B.S., Electrical and Computer Engineering, with distinction
(1986)
Affiliations
Steering
committee for the Rochester Business Ethics Award. Leadership Rochester
class of 2004. American, New York State and Monroe County Bar Associations. Order
of the Coif.
Joe Bradley
Joe Bradley earned an MBA from the University of
Illinois at Urbana-Champaign, Master’s in Mechanical Engineering from Iowa State University, and a Bachelor’s
in Aerospace Engineering from the University of Michigan. Joe is currently
working towards a Ph.D. in Systems and Entrepreneurial Engineering, also
at Illinois.
Joe has 5 years work experience in the consumer product and consumer software
industries, including a position as Applications Engineer at EDS. The breadth
of Joe’s experience is illustrated by accomplishments as diverse as an issued
patent for a child safety device and a computer program he designed to analyze
the neurological behavior of diabetic and heart transplant patients that
was used at Baptist Hospital in Memphis.
After completing the Commercialization Analyst internship in 2003-2004 and
2004-2005, Joe remained on the team to manage two large-scale disclosure-mining
project in 2005-2006, one in the NanoCemms Center,
the second at the Beckman Institute. Both are anticipated to bring additional
invention disclosures to the OTM.
John Boruvka
John Boruvka, vice
president for Iron Mountain’s Intellectual Property Management business
unit, has been involved in the technology escrow field for more than 18
years. His focus is helping companies create solutions relating to protecting
intellectual property assets.
Before
joining DSI Technology Escrow Services (later acquired by Iron Mountain
in 1997), Mr. Boruvka was an account executive
for SunGard Planning Solutions, a disaster recovery and contingency
planning firm. There, he worked with Fortune 500 IT installations to implement
software to manage and create disaster recovery plans.
Mr. Boruvka is
considered an authority in the field of technology escrow and issues surrounding
the role of a neutral third party in protecting intellectual property. He
has participated in the development of strategies and review of thousands
of technology escrow agreements for software, hardware and other proprietary
information that established to protect against mergers, bankruptcies or
other events that affect the ability of vendors to support their technology.
Mr. Boruvka written many articles and has also presented at numerous
associations and prestigious law firms across the United States, Canada,
South America and Europe.
Cheryl L. Cejka
Cheryl currently leads technology commercialization
activities for Battelle’s Pacific Northwest Division
in Richland, Washington. She has the responsibility for all intellectual
property management, portfolio development and investment, and technology
commercialization activities at Battelle’s Pacific
Northwest Division and on behalf of Battelle at
Pacific Northwest National Laboratory. Since taking on this role in 2001,
Cheryl has made many changes in PNNL’s licensing
program, resulting in sustained revenue growth and increased efficiency.
During her 25 years at Battelle,
Cheryl has held a broad range of business management and technology development
positions. Areas of expertise include finance, contracts, risk management,
licensing and commercialization. Cheryl has also led many organizational
change and process improvement activities across Battelle in
the areas of financial performance, intellectual property, contracting, and
client relations.
Cheryl has been recognized for her achievements
in the areas of new business development, organizational redesign, licensing
and commercialization and for leading the Economic Development and Technology
Transfer component of Battelle’s successful 1999
bid to operate the Oak Ridge National Laboratory. She was selected as PNNL’s 1993
Woman of Achievement.
Cheryl received an MBA in finance from the University
of Washington in 1985 and obtained her bachelor’s degree in Marketing and
Human Resources from the University of Washington in 1980. Cheryl has also
been named a fellow with the National Contract Management Association.
Pamela L. Cox
Pamela L. Cox
is a partner at Marshall, Gerstein & Borun.
Ms. Cox concentrates on licensing and
other transactions related to intellectual property for a wide range of
clients from start-up organizations to non-profit institutions to international
corporations.She also has expertise in biotechnology prosecution, opinion
work and client counseling.
Before attending
law school, Ms. Cox served as the associate director of technology transfer
at Indiana University where one of her responsibilities was managing the
university’s
eight campus patent portfolio. Previously, Ms. Cox worked in regulatory
affairs at DePuy Inc., a Johnson & Johnson
Company, as a regulatory affairs microbiology
analyst specializing in sterilization and regulatory compliance. Ms. Cox
is admitted to practice law in the state of Illinois and before the U.S.
Patent and Trademark Office. Ms. Cox received her J.D. from the University
of Notre Dame School of Law and holds a B.S. in biology from Indiana University.
A
frequent speaker and active participant in several licensing organizations,
Ms. Cox is president-elect for the Licensing Executive Society of Chicago,
a sub-committee chair of the Licensing Committee of the Intellectual Property
Owners Association, a member/editor of the Technology Transfer Manual task
force for the Association of University Technology Managers, as well as
a member of the American Intellectual Property Law Association, the American
Bar Association and the Illinois Bar Association.
Dennis M. DeLeo
Denny DeLeo has
managed business aspects of technology development, commercialization and
protection. As a Kodak Vice President, he directed a corporate staff responsible
for a wide range of technology-based transactions, including, licensing,
business partnerships and acquisition and divestiture of technology, products
and businesses.
DeLeo also held
Kodak operating management positions as Vice President and General Manager
of the Bioscience and Emerging Businesses Division and Vice President,
General Manager of the Image Acquisition Products Division. The latter
commercialized image-sensing technology into electronic camera and scanner
products. He also served as President and CEO of Eastman Technology, Inc.,
a Kodak subsidiary formed to launch businesses based on leading-edge technologies. As
chief executive, he had overall profit-and-loss accountability and managed
a portfolio of more than a dozen new ventures.
DeLeo is a founding
general partner of Trillium Group, LLC, and the managing executive of the
Monroe Fund, a venture capital fund targeting startup, technology-based businesses.
He holds a B. A. from the University
of Rochester, a J.D. from the University of Chicago Law School and completed
the Advanced Management Program at the Harvard University Graduate School
of Business. He is a former member of the Patent Policy Board of the State
University of New York, a former vice chairman of the Rochester Philharmonic
Orchestra Board and a former board member of Genencor International. He
is currently a member of the Boards of Directors of Scene Genesis, Inc.
and Election Services Corporation.
Charley Eberhard
Charley Eberhard is
a licensing manager in Procter &
Gamble’s External Business Development organization. He has responsibility
for licensing and technology transfer (both in and out) for P&G Beauty.
This work includes creating the right business models that maximize value
creation for P&G and its partners.
Charley began his career with the company
in 1990 as an engineer in the paper business. He has been in External Business
Development for 5 years where he managed the engineering licensing practice
prior to his work on P&G Beauty.
Melea East
Melea East, BBA, JD, joined the Office of Technology Development at the University of Louisville, now the Office of Technology Transfer, as
its Assistant Director in the fall of 2001. Originally from Louisville, Kentucky, she earned
her BBA in Finance from the University of Kentucky, graduating summa
cum laude, and her JD from the University of Louisville, where she achieved
high distinction in Criminal Procedure, Negotiable Instruments and Securities
Law. Prior to joining the Office, she worked for a medical supplies
distributor and as an associate at Brown, Todd and Heyburn, now Frost
Brown Todd, in Louisville, Kentucky, where her practice focused on corporate
intellectual property. She is currently serving as Deputy Director of
the Office.
Ms. East is admitted to practice before the
Kentucky Bar and is a member of the Louisville Bar Association. Ms. East
has presented twice at the national AUTM meeting and is an active member
of AUTM, LES and OVALS (the Ohio Valley Affiliates for Life Sciences). She
is also an active member of Young Professionals Association of Louisville
and serves on the Board of Directors for the Louisville Ballet.
Thomas J. Engellenner
Thomas J. Engellenner
is a partner and a co-chair of Nutter's Intellectual Property and Life Sciences
practice groups. His practice includes patents, trademarks, copyrights, licensing,
and litigation. He has particular expertise in the patenting and licensing
of biotechnology, pharmaceuticals, and medical devices. Tom began his career
as a trial attorney for the U.S. Environmental Protection Agency. Prior to
entering the private practice of law, he was an associate patent counsel
at the Massachusetts Institute of Technology. Active in the bar, Tom is a
member of the American, Massachusetts, and Boston Bar Associations, the American
Intellectual Property Law Association, and served as president of the Boston
Patent Law Association in 2000-2001. He is also a member of the Licensing
Executives Society and the Association of University Technology Managers. Tom
was named by Boston
Magazine as a “Massachusetts Super Lawyer” in intellectual property in
both 2004 and 2005.
Steven M. Ferguson
Steven M. Ferguson currently
serves in the NIH Office Of Technology Transfer as the Director and senior
licensing professional for a fifty-member Division of Technology Development
and Transfer, the patent & licensing group for NIH and FDA technologies. Prior
to rejoining NIH in 1990, Mr. Ferguson served in marketing and management
positions in such biomedical firms as Pharmacia Fine Chemicals and LKB Instruments
subsequent to being a scientist at the National Cancer Institute. His healthcare
experience has also included work as Director of Marketing and Public Relations
for a rural 70-bed hospital.
A registered Patent Agent, Mr. Ferguson holds Master's
Degrees in Business Administration (George Washington University) and Chemistry
(University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case
Western Reserve University).
Mr. Ferguson is a project reviewer for Maryland
Industrial Partnerships (MIPS) as well as the Advanced Technology Program
(ATP) and is the licensing instructor for both the USDA Graduate School
and two NIH FAES courses on Technology Transfer and Biomedical Business
Development. He is the co-author of Starting & Operating A Business
in the District of Columbia and Starting & Operating A Business
in West Virginia, both published by Oasis Press. Mr. Ferguson was
also the Susan T. and Charles E. Harris Visiting Lecturer at the Watson
School of Biological Sciences at the Cold Spring Harbor Laboratory and
has published articles on licensing and technology transfer issues in such
publications as Journal of Biolaw and Business,
Journal of Pharmaceutical Development & Regulation, Drug Discovery
Today, Personalized Medicine, Nature Biotechnology, AUTM
Journal and Current Drug Discovery Technology.
He has received the NIH Director’s Award
and six NIH Merit Awards in recognition of his activities in the management
and negotiation of technology licensing agreements from the National Institutes
of Health.
Walter Flamenbaum
Dr. Flamenbaum is
the Managing Partner of the Paul Royalty Fund, and has led the development
and refinement of its investment strategy, processes and techniques, as
well as actively participated in the majority of the Fund’ investments,
including roles in sourcing, negotiating and other activities. His broad
based medical knowledge and experiences provides the Fund with a unique
resource for healthcare investing. Dr. Flamenbaum was
primarily responsible for the development of diverse team of healthcare
and financial investment professionals, allowing for the Fund’s development
and successes to date.
Dr. Flamenbaum has
35 years of healthcare experience, including the development and evaluation
of pharmaceutical and biotechnology based-drugs, medical devices and diagnostics. During
the 10 years prior to joining Paul Capital Partners in 1999 as a founding
member of the Paul Royalty team, he had extensive experience in the licensing
of healthcare product-related intellectual properties and the assessment
of healthcare investment opportunities. He also founded a contract research
organization, started a biomedical company, as well as having senior management
responsibilities in a biotechnology company.
He is board certified in internal medicine,
nephrology and clinical pharmacology and was a professor of medicine at
the Mt. Sinai School of Medicine and Tufts University School of Medicine. Dr. Flamenbaum served in the U.S. Army at the Walter Reed Army
Institute of Research and the Walter Reed Army Medical Center. He earned
his M.D. from Columbia University’s College of Physicians & Surgeons
and his B.A. from Washington &
Jefferson College. Dr. Flamenbaum received his
training in Internal Medicine at the Hospital of the University of Pennsylvania,
and his nephrology training at Peter Bent Brigham Hospital.
Joseph D. Fondacaro
Dr. Fondacaro is currently Director of Intellectual
Property and Venture Development for the Cincinnati Children’s Hospital Research
Foundation.
Dr. Fondacaro received his Ph.D. in Physiology in 1972 . Following
a 3-year postdoctoral fellowship at Albany Medical Center in New York,
he became Associate Professor of Physiology at the Cincinnati College of
Medicine. Dr. Fondacaro then joined the pharmaceutical
industry, initially with what is now GlaxoSmithKline and later with Marion
Merrill Dow, now Sanofi-Aventis, as a scientist
in discovery research and as Director of Sponsored Research where he became
involved in licensing activities. In 1996, Dr. Fondacaro joined
Children's Hospital Research Foundation of Cincinnati to establish an office
of technology transfer.
Dr. Fondacaro serves on the Board of Directors of the Cincinnati
Foundation for Biomedical Research and Education and of BioStart Biomedical Incubator. He holds a faculty position
at the University of Cincinnati College of Medicine and lectures on Ethics
in Intellectual Property Management. Dr. Fondacaro also teaches a 2-day course entitled “Bridging
the Gap; Creating an Office of Technology Transfer”, is an active member
of the LES and AUTM and has published relevant articles on university licensing
and technology transfer. He is a past chair of Industry/University/Government
Laboratories Transaction Committee for LES and is currently Vice President
of Professional Development for AUTM.
James J. Foster
Jim Foster is a shareholder at Wolf, Greenfield & Sacks,
P.C., an intellectual property law firm of over 60 professionals located
in Boston, Massachusetts. Jim chaired for eight years, and is now a senior
member of, the firm’s Litigation Practice Group, and is also a member of
the firm’s Executive Committee.
Jim is among the most experienced patent
trial lawyers in the country with 30 years of trial practice, specializing
in patent, trademark, copyright, and trade secret litigation. His jury
experience is extensive, as he has been lead counsel in patent jury trials
not only in Massachusetts, but in seven other states as well. He is also
an accomplished appellate advocate, having argued numerous Federal Circuit
patent decisions, including landmark cases.
Jim received his undergraduate degree in
Electrical Engineering from Massachusetts Institute
of Technology and his law degree from Harvard Law School. Jim is
an active member of the Litigation Committee of the Boston Patent Law Association,
the Federal Practice and Procedure Committee of the American Bar Association
Intellectual Property Law Section, the Intellectual Property Subcommittee
of the American Bar Association Litigation Section, and the Federal Circuit
Bar Association. He has frequently lectured on subjects related to intellectual
property litigation to different patent law organizations and at various
bar meetings. He has been widely published in such publications as New
York Bar Journal, Journal of the Patent and Trademark Office Society, New
England In-House Counsel magazine, and Mass High Tech. Jim has also been named in Boston Magazine as
one of Massachusetts' "Super Lawyers" in the field of patent
litigation.
Mr. Kelly Frey
Kelly Frey concentrates his practice in
the area of technology law, including the representation of both large
corporations and vendors to such companies in procurement transactions
involving information technology. Mr. Frey also regularly advises
clients on intellectual property matters (including copyright, trademark,
trade secret, domain name, Internet and e-commerce issues) and serves as
the principle legal resource for new business ventures in the information
technology industry.
Mr. Frey has published across the breadth
of technology topics and has spoken extensively on intellectual property
issues before such national forums as Internet World, National Online,
the American National Standards Institute (ANSI), PC Forum, Internet Expo
and Library of Congress-Copyright Office sponsored programs, as well as
at state and local bar association events from California to New York.
Christine T. Fischette
Christine T. Fischette, Ph.D.,
Head, Negotiations, General Medicine Business Franchise, Global Business
Development and Licensing, Novartis Pharmaceuticals. Chris has 20+ years
experience in the pharmaceutical industry and has been actively engaged
in all stages of drug development from concept to marketed product. Her
breadth spans bench level research at Hoffmann-La Roche through several
functions at Pfizer with increasing responsibility for clinical development
(Phase I – IV), project management
(IND/NDA submissions), medical marketing (strategy and implementation),
marketing (head of US commercial division for diabetes) and business
development. In her present capacity at Novartis she
has identified, analyzed, negotiated and executed a number of deals with
both Biotech and Big Pharma (US, EU and Asia) incorporating a variety of different
deal structures. Christine received her B.A. at Rutgers University, Ph.D.
at the University of Medicine and Dentistry of New Jersey and earned
a Post-Doctoral Fellowship award at Rockefeller University. She has
authored over 50 original research publications.
Paul Germeraad
Paul Germeraad is
President of Intellectual Assets, Inc., a professional advisory services
firm specializing in integrated business, R&D, and IP processes. Intellectual
Assets, Inc. is distinguished by using cutting edge IP assessment tools
and proprietary software, in addition to offering invaluable insight based
on the depth and breadth of executive level management experience and industry
coverage the firm’s members represent.
Dr. Germeraad was
previously Chief Operating Officer for Aurigin Systems,
Inc., a software start-up company, where he focused on the development
of the company's intellectual asset management products for the Competitive
Intelligence, Licensing and R&D communities. Prior to joining Aurigin in 1998, Paul worked for three Fortune 500 companies. He
served as Vice President, Corporate Research for Avery Dennison, as the
executive responsible for the Corporate Research Center. Before joining
Avery Dennison, Paul was director of James River Corporation's Flexible
Packaging Technical Center and held a variety of R&D and management
positions at Raychem Corporation.
Paul is past Chairman of the Industrial Research
Institute, an organization of Chief Technology Officers whose organizations
account for over 70% of all US R&D spending. Paul joined the Licensing
Executives Society (LES USA-Canada) Board of Trustees in 2002 and served
as Vice President, Education for the 2004-2005 year. He is an instructor
for the LES Professional Development Series and Chair of the LESI Education
Committee 2005-2006.
Paul is a graduate of the University of California,
San Diego, with a B.A. in Chemistry. In addition, Paul holds a Ph.D. in
Chemistry from the University of California, Irvine and an LL.B degree
from La Salle University.
David Ghesquiere
David Ghesquiere, Vice President,
Business Development, OSI Pharmaceuticals, Inc. At OSI, David’s primary
responsibilities include formulating the Oncology business development strategy,
building relationships with Oncology companies, licensing and acquisition
of Oncology assets, outlicensing and alliance
management.
Prior to joining
OSI in 2005, David was Director of Global Business Development at Aventis Pharma SA. Based in Paris,
France, his responsibilities included Oncology business development.
Based in Bridgewater, New Jersey, he was the Global Business Development
leader for the collaboration with Regeneron for VEGF-trap, which Aventis signed
in 2003. David was previously responsible for licensing in the Rheumatoid
Arthritis therapeutic area and managed a global divestiture for the
company.
Prior to joining Aventis in
2001, David was with Johnson &
Johnson in the US and Canada, where he held several positions in New Business
Development and Marketing.
Education: David holds an MBA from the Richard Ivey
School of Business (formerly the Western Business School) in London, Canada,
and a Bachelor of Arts degree in Economics from the University of Western
Ontario.
Heinz Goddar
A German
Patent Attorney and European Patent and Trademark Attorney. Partner of Boehmert & Boehmert
and of Forrester & Boehmert, with his office
at Munich. Technical background (as well as PhD degree) in physics and
physical chemistry. Before his career as a patent attorney Assistant of
Professor at the Polymer Department of the University of Mainz, Germany.
He is one of the senior partners of his firm and is particularly involved
in international patent and licensing matters, including litigation and
arbitration. He is an Associate Judge at the Senate for Patent Attorneys
Matters at the German Federal Court of Justice and a Senior Advisor to
the German Industrial Investment Council (IIC), Berlin, with a specific
responsibility for IIC Life Sciences and Chemicals. He teaches Patent and
Licensing Law as a Lecturer at the University of Bremen, Germany, and the
Munich Intellectual Property Law Center (MIPLC),
Munich, Germany, and as a Visiting Professor at the University of Santa
Clara, CA, U.S.A., the University of Washington, Seattle, WA, U.S.A., the
National ChengChi University, Taipei, and the
Tokai University, Tokyo. He is a Past President of LES International and
of LES Germany. Contact and further informations: goddar@boehmert.de, http://www.boehmert.de.
Markus Goebel
Markus Goebel, MD, PhD, Managing Director of Novartis
Venture Fund has more than 16 years in the industry across
functional and therapeutic areas.
Dr. Goebel has had a breadth and depth of
experience in R&D, Strategic Marketing, Business Development
& Licensing and Mergers & Acquisition, with Novartis and
previously with Roche. Prior positions at Novartis include
Global Head of Pharma Corporate M&A and Global
Head Nervous System BD&L Pharma.
A M.D. by training and certified, amongst
others, in Hematology/Oncology, he worked for Farmitalia Germany and later held several positions in R&D,
Marketing and Strategy at Roche headquarters before joining Novartis.
Markus received a M. D. and a Ph. D. from
the Ludwig Maximilian’s University in Munich and a MBA from Henley.
Nathan L. Golden
Mr. Golden is a Licensing Executive in the
Corporate Business Development and Partnerships organization (CBD&P)
at Sandia National Laboratories. He is responsible
for the management of intellectual property through a strategic intellectual
management and portfolio process, which includes the negotiation of license
agreements for selected organizations within Sandia. His
responsibilities also include assisting Sandia inventing
organizations in the management of issued patents. Prior to joining the
CBD&P organization in 2003, he was a corporate internal auditor at Sandia National
Laboratories and performed environmental, safety and health (ES&H)
audits of Sandia’s programs. He has been at Sandia over
twenty years and has held a variety of professional positions while employed
at Sandia.
Mr. Golden is the local New Mexico LES Chapter
chair. He is also a co-chair for the Industry, University and Government
Transactions Sector - LES (FY 2007).
Mr. Golden earned a MBA/MIS from New Mexico
State University in 1984 and a bachelors in chemistry from New Mexico State
University in 1982. He is one of two BEAC Certified Professional Environmental
Auditors at Sandia.
Theodore D. Goldman
Ted’s background includes 30 years of experience
in the chemical and allied industries. He worked for the Rohm and Haas
Company for 26 years. Ted held many positions of increasing responsibility
focusing on plastics, plastics additives, petroleum chemicals, agricultural
chemicals and electronic chemicals. He was a research chemist, chemical
process analyst, product development manager and manager of training and
development. He then started his own consulting business. In 2005, Ted
joined The Martec Group.
As a Senior Consultant with Martec’s Specialty
Chemical and Engineered Materials Business Team, Ted conducts strategic
market research to help clients make strong business decisions on technology,
products and markets. He has significant experience in supporting university
technology transfer offices and in supporting new business start-ups.
Ted earned a Ph.D. in Chemistry from New
York University, was an NIH Postdoctoral Fellow at the University of Wisconsin,
and earned a Certificate in Business Administration from the Wharton School.
Larry Goldstein
Larry Goldstein is Vice President at Sedna Patent Services, which is a consortium of companies
formed to help manage patent rights in the cable business. Larry’s responsibilities
include managing a portfolio of U.S. and international patents, representing
the company on patent pools, identifying and evaluating patent portfolios
for possible investment, and out-licensing of various patents.
Prior to working at Sedna,
Larry helped launch the 3G UMTS patent pool, and managed intellectual
property for various telecommunication companies, including Comverse Network
Systems (a supplier of software products to large telephone companies),
Motorola, and several semiconductor companies. Prior to his corporate
work, he was a commercial litigator in the areas of contracts and antitrust.
Larry holds a B.A.
from Harvard College, an MBA from Northwestern University, and a JD from
the University of Chicago. He
is a registered U.S. patent attorney, and the incoming chairman of the
Standards Committee of the High Tech Sector within LES. He is a co-author
of the book Technology Patent Licensing: An International Reference
on 21st Century Patent Licensing, Patent Pools and Patent
Platforms (Aspatore Books, Boston, 2004).
Peter
Gordon
Mr. Gordon has
been practicing in the patent field for over 15 years. Prior
to joining Avid Technology, Inc., he was a partner of Wolf, Greenfield & Sacks,
P.C., Boston, Mass., where he was chair of the computer software patent
practice group. Educational
Background:Suffolk University
Law School, J.D., cum laude. Massachusetts
Institute of Technology, S.B. Computer Science and Engineering.
Noel Hall
Has more than 20 years experience in the
pharmaceutical industry. Prior to establishing Aspreva,
Mr. Hall founded the Life Sciences practice of Hill and Knowlton and led
the firm’s global strategic planning for the worldwide pharmaceutical practice.
Aspreva’s vision
is to change the treatment landscape for people living with less common
diseases by identification, development and commercialization of existing
medicines for new indications.
In 2003, Aspreva gained
the worldwide rights (excluding Japan) from
Roche to develop and commercialize their leading transplantation drug,
CellCept (mycophenolate mofetil/MMF), in all autoimmune disease applications
with the rights to new formulations through 2017.
Aspreva’s partnering
strategy enables pharmaceutical and biopharmaceutical companies to develop
their drugs, clinically and commercially outside of their products’ strategic
focus.
Noel Hall currently serves as a director
of the Canadian Genetics Diseases Network.
Steven J. Henry
Steve Henry is a shareholder at Wolf, Greenfield & Sacks,
P.C., an intellectual property law firm of over 60 professionals located
in Boston, Massachusetts. Steve co-chairs the firm’s IP Transactions Group
and is a member of the firm’s Electrical & Computer Technologies Group.
Steve has broad experience in all aspects
of intellectual property, with special expertise in the protection of computer-related
inventions (hardware and software), analog and digital circuits and systems,
communications, semiconductors, MEMS devices, and communications and control
systems. His practice spans the entire range of prosecution, litigation,
licensing and client counseling.
Steve was co-counsel to Signature Financial
Group and architect of the landmark decision it won from the Federal Circuit
in 1998 in State Street Bank and Trust v Signature Financial Group.
That decision opened the door to patents for business methods.
Steve is a frequent speaker at legal and
industry conferences such as the Massachusetts Computer Software Council,
MIT Enterprise Forum Technology Transfer Conferences, European Technology
Roundtable Exhibitions (ETRE), Israel Export Institute, Massport Export Seminars, and Licensing Executives Society,
among others. He has written for legal, technical and business publications.
For several years, he was an adjunct professor at Suffolk University Law
School, where he taught patent law. He also has served as an arbitrator
in technology-related disputes.
Steve holds Bachelor's and Master's degrees
in Electrical Engineering from the Massachusetts Institute of Technology,
and received his law degree from Georgetown University Law Center. He is
a member of a number of associations and is listed in Who's Who in American
Law.
Michele K.
Herman
Michele Herman
attended Rutgers University and graduated with a BS in Electrical Engineering
and a JD. She was employed as an engineer by RCA and Magnavox, designing
communication systems as well as detection and tracking systems. Michele
joined the law firm of Woodcock Washburn in Philadelphia in 1989, where
she specialized in all aspects of intellectual property law.
In 1997, Michele
moved to Redmond, Washington, to join Microsoft’s Patent Group as a Corporate
Attorney supporting the Consumer Platforms Division at Microsoft. While
at Microsoft, Michele formed and led a legal team specializing in standards-related
issues. She then became Senior Director of Intellectual Property, where
she was responsible for facilitating, coordinating, and overseeing the
development and implementation of intellectual property and standards strategies
as an integral part of Microsoft’s business and product plans on a company-wide
basis. Most recently, Michele was Associate General Counsel in Microsoft’s
Intellectual Property and Licensing Group.
In December, 2004,
Michele returned to private practice at Woodcock Washburn’s Seattle office,
where she focuses on legal matters relating to industry standards and open
source software.
Thomas Hofstaetter
Thomas
Hofstaetter, Ph.D., joined Wyeth in September of 2004 as Senior
Vice President, Corporate Business Development. He also serves as a member
of the Wyeth Management Committee.
As Senior Vice President, Dr. Hofstaetter is
responsible for corporate and pharmaceutical business development for Wyeth.
Before joining Wyeth, Dr. Hofstaetter worked for Aventis,
where he served as Senior Vice President, Corporate Development. Prior to
the merger that created Aventis, Dr. Hofstaetter was
Senior Vice President, Business Development and Strategic Planning, for Hoechst
Marion Roussel from 1995 through 1998 and was Executive
Managing Director of Hoechst Japan Pharmaceuticals from 1991 to 1994. He
previously worked for Behringwerke AG in Germany,
where he started as a Research Scientist in 1978 and rose to Head of Research
in 1988.
Dr. Hofstaetter received his Ph.D. in Biochemistry/Molecular
Biology, magna cum laude, from the University of Tuebingen in
Germany.
Kevin Jakubenas
For the last two
years Kevin Jakubenas has been the Los Alamos
National Laboratory (LANL) – Procter & Gamble Industrial Fellow, acting
as the coordinator of R&D between the two organizations. During that
time, he conducted technology scouting activities to identify areas of
mutual research interest in LANL’s and P&G’s $4 billion
combined R&D budgets across technical disciplines as diverse as nanotech,
biotech, and fundamental chemistry and physics. The keys to success in
this endeavor have been to identify seemingly unconnected problems that
have common scientific solutions and to recognize where P&G and LANL
technical strengths complement each other.
Prior to the LANL-P&G
Industrial Fellow assignment, Dr. Jakubenas’
work in the LANL Technology Transfer division focused on identifying market
applications of LANL intellectual property, particularly related to start-up
companies. Previously, Dr. Jakubenas worked at a nanotechnology start-up company and
as a researcher in both government and university laboratories.
Dr. Jakubenas received
a BS in Mechanical Engineering and MS and PhD degrees in Materials Science
and Engineering from the University of Texas at Austin, where he was a
National Science Foundation Fellow. He also earned an MBA degree from
UT-Austin with a concentration in operations management.
Michael Janse
Michael
is an Associate with ARCH Venture Partners. He currently concentrates on
investment opportunities in advanced semiconductor products, communications
infrastructure, and novel materials. Mr. Janse currently supports ARCH portfolio
companies Crystal-IS, ALIS, Univa and AlfaLight. Michael previously
worked in Motorola's Semiconductor Products Sector as a process engineer
and marketed semiconductor components to manufacturers of personal computers
and networking products. He holds an M.B.A. from The University of Chicago
and a B.S.in Chemical Engineering
from Brigham Young University.
John C. Jarosz
Mr. Jarosz has
significant expertise evaluating and testifying on damages in patent, trademark,
copyright, trade secret and unfair competition cases. He has worked on
such landmark cases as the Kodak/Polaroid patent infringement litigation,
and the Apple Computer/Microsoft/Hewlett-Packard copyright infringement
litigation. He has assisted clients across a variety of industries, including
semiconductors, computer hardware and software, medical devices, consumer
products, biotechnology, and pharmaceuticals. He has testified at trial
on intellectual property issues over two dozen times. Mr. Jarosz has been
both a columnist and advisory board member of The IP Litigator and
is a frequent lecturer and writer on intellectual property issues. He
has a J.D. degree from the University of Wisconsin, an M.A. in Economics
and was a Ph.D. candidate in Economics at Washington University, St. Louis
and a B.A. from Creighton University.
Gunnar Leinberg
Gunnar Leinberg
is a partner and registered patent attorney with the firm of Nixon Peabody
LLP. He received his BS in electrical engineering summa cum laude in
1987 and his J.D. from Georgetown University Law Center in 1990. For the
past sixteen years, he has been actively
involved in counseling clients, ranging from independent inventors and
small start-ups to universities and large multinational companies, on the
strategic management, procurement, licensing, and enforcement of their
intellectual property rights. Mr. Leinberg works
closely with his clients to ensure that their patent strategy is consistent
with their business model and objectives. He is actively involved in the
preparation and prosecution of patent applications, has extensive experience
in providing non-infringement, invalidity, and clearance opinions and regularly
assists with intellectual property due diligence investigations. Additionally,
Mr. Leinberg is involved in intellectual property related litigation
proceedings before the US Patent and Trademark Office and in Federal Courts. He
regularly speaks across the country and writes articles on a variety of
topics, including intellectual portfolio strategies, the procurement of
patents, trademarks, and copyrights, the impact of recent intellectual
property case law, such as on business methods and prior art issues, pending
legislation, such as the Patent Reform Act of 2005, and on licensing matters.
Terry Ludlow
From
the basement of his family’s home to
an international presence, Terry Ludlow
has driven the Chipworks odyssey.
Although Chipworks is not in any
way a one-man show — he’s had a lot
of help along the way — it is Terry who
has provided the strategy, the vision,
and the driving force for the company.
Terry
first caught the reverse engineering obsession
when he worked at Mosaid Technologies. Hand’s on analysis
of a broad array of memory chips
quickly taught Terry about IC design
and the value of reverse engineering.
After
a few years of running the reverse engineering group
for Mosaid the success
of the progenitor of the Patent Intelligence
business was perceived as a conflict
with Mosaid’s Design and Tester business
units. Mosaid decided to shut the
reverse engineering business down. Responding
to customer demand and his
need for a job, Terry started Semiconductor
Insights with funding from
a client and initial support from Mosaid.
As well as the technical competitive
analysis at SI, Terry expanded
the intellectual property (IP) side
of the business. Reverse engineering
was an established concept for
technical intelligence, but Terry was among
the first to see its value for patent
lawyers and the industry’s IP groups.
Both
sides of the business took off under
Terry’s leadership, but after a few years,
his vision and strategy no longer matched
that of the company’s client ownership.
The
only answer
— the way to put his vision
into practice — was to start his own
company, and so, in 1992, the stage
was set for Chipworks. At this point,
the stage was only the basement and
spare bedroom of his house, but you
have to start somewhere.
The
company began with Terry and after
a few months a few engineers on contract.
After about a year and a half full
time employees were added — Julia Elvidge being
the first — and an administrator,
then quickly reached 15 people
as the demand for reverse engineering
increased. It became apparent
that 15 people was too many for
Terry’s house, so the business moved
to its first premises in central Ottawa.
In
the early years, Terry concentrated on
Asia, a huge market for reverse engineering services.
Here, Terry’s capabilities
and values, imaginative commitment
to customers, and focus on excellence
were immediately successful. “We
have a passion for excellence and a commitment
to our clients, and our customers
could see this from the early days,” says
Terry. “They know we’ve always
worked for them, and they use us
as an extension of their own company.” Now
the company has offices in
North America, Japan, Poland, Korea, and
Taiwan, representation worldwide, and
clients around the globe.
With
a restructuring in 2005, Chipworks has
about 100 employees spread over three
divisions: Technical Intelligence,
Patent Intelligence, and Core Capabilities,
which manages the infrastructure.
It’s never been hard to attract people
to Chipworks. For one thing, Terry
isn’t the only techno maniac out there — most
of the Chipworks employees are crazy about microelectronics.
The other major factor is the company’s
philosophy. Naturally, there have been
changes over time, but the basic values
remain constant: teamwork and
sharing knowledge in a supportive environment
bringing out the best in everyone.
It’s also vital to reward people
for their work. For example, an early
profit-sharing scheme developed into
a bonus system, then more recently
into shares in the company.
Open communication
between employees and
management has always been a keynote
of Terry’s management style. This practice
was easier to maintain with
a company of 15 individuals,
but it’s still the most important management
objective at Chipworks — it just takes more thought and care.
As the company
has grown, so has the semiconductor
industry. One of Terry’s tasks is to keep
track of trends.“Scaling challenges
and mobile personal devices are driving
the industry in an environment more
competitive than ever,” he says. “Penalties
are severe for companies that
get it wrong.”
As Terry explains, “The
outsourcing trend is good
for us. Most companies can’t do competitive
analysis for themselves any
longer. A decade ago, you could do
reverse engineering with a $40,000 microscope.
Now you need $10 million worth
of equipment and specialized research.”
On the patent
intelligence side, the picture for Chipworks is equally rosy. Terry says “The
value of intellectual property is constantly
rising, so the market demand
for Chipworks services is always there.
In the information age, it’s good to
be an information provider.Our information
helps our clients improve their
products and their licensing positions,
so we’re always in demand.”
And now, with
the day-to-day running of the company
in Julia Elvidge’s (Chipworks’
President since 2003) capable hands,
Terry, as CEO, is free to pick and chose
his activities. He can indulge his passion
for the leading edge of microelectronics — the
latest and greatest iPOD, or a gyroscopic golf club.He can study
business management practice, and
keep up his involvement in the marketing
side of the company.Most of all,
this role allows Terry to concentrate on
his favourite aspects of the business:
strategy, vision, and the drive to the
future.
“The opportunities
are all out there,” he says, “we just
have to choose the right ones.”
Robert S. MacWright
Dr. Robert MacWright is
Executive Director and CEO of the University of Virginia Patent Foundation,
which evaluates, protects, and licenses inventions made at the University
of Virginia. Dr. MacWright also serves as the
CEO of Spinner Technologies, Inc., a subsidiary of the Patent Foundation
that encourages and supports faculty entrepreneurs and the technology-based
start-up companies they form. Dr. MacWright holds
a Ph.D. in biochemistry, and is also a Registered U.S. Patent Attorney. He
formerly practiced law in the IP practice group at Skadden, Arps, Slate, Meagher & Flom,
L.L.P., and also at the IP law firm of Kenyon & Kenyon. Dr. MacWright
has been involved in the university licensing profession since 1985.
Michael McCartney
Michael McCartney has been with Semiconductor Insights since 1999, over
this time he has served in various roles in the company including IP Services
Account Manager.
During this time he has played a large role in the development and implementation
of Semiconductor Insight's patent services, such as, Patent Development services,
IP Landscape Services, and Campaign Assessment Products.
This service development role was derived from his experience as an IP Account
Manager where he led several offensive licensing campaigns, and several defensive
licensing campaigns. While in this role he provided guidance on patent
selection and interpretation, target product selection and technical assessment
of infringement for his clients
He also authored an article on IP in the CMOS Image Sensor market, entitled “IP
Key In CMOS Imagers”, in the EETimes published March 27, 2006.
Robert B. McGrath
Robert McGrath joined Drexel University in
December, 2005 as Associate Vice Provost and Executive Director for Technology
Commercialization, where he directs the licensing of intellectual property
developed at the University. For the previous six years, Dr. McGrath commercialized
technologies at the University of Pennsylvania’s Center for Technology
Transfer, having assumed roles with increasing responsibility during his
tenure there. He held the position of Director of Technology Licensing
immediately prior to joining Drexel. In addition to serving as a consultant
to venture capital, he was an academic researcher for nearly fifteen years,
including doctoral studies at The Rockefeller University, and postdoctoral
research at Penn.
Thomas F. Meagher
Thomas F. Meagher focuses his practice on patent litigation and prosecution
and has extensive experience working with electronic, computer, telecommunications
and biomedical technology companies. Mr. Meagher has handled patent matters
at all phases of litigation and trial, having served such worldwide clients
as Agilent Technologies; Boston Scientific Corp.;
Intel Corp.; Hewlett-Packard Corp.; Home Shopping Network; Hitachi, Ltd.;
Wang Laboratories; Nan Ya Plastics Corp. of Taiwan;
and Microsoft Corporation. He has assisted the General Electric Company in
patent licensing negotiations in Asia. He has also managed extensive prosecution
work for research institutions, including Princeton University, the University
of Southern California, Massachusetts Institute of Technology, and Sarnoff
Laboratories, and advises clients on strategies aimed at maximizing intellectual
property protection while minimizing infringement risk.
Mr. Meagher's professional background spans more
than 25 years, initially as patent counsel in-house for ITT Corporation and
as a member of the Patent Department for RCA Corporation as well as nearly
two decades with Kenyon & Kenyon prior to joining Duane Morris. Mr. Meagher
currently serves as a member of the National Patent Advisory Council of the
American Arbitration Association and is a member of the New York and New
Jersey Intellectual Property Law Associations, the Intellectual Property
Owners Association, the Licensing Executives Society (U.S.A. and Canada),
the Association of University Technology Managers, the New Jersey Technology
Council, and the Princeton Bar Association.
Mr. Meagher is a co-author of "Academics Must Protect Their Patent
Rights," The Chronicle of Higher Education, May 27, 2005; and
a speaker and moderator of the presentation "Patent Issues Facing
Universities" at the LES 2006 Winter Meeting, Pasadena, California,
February 24, 2006.
Mr. Meagher is a 1982 graduate of the Catholic University of America, Columbus
School of Law, and a graduate of Carnegie Mellon University (B.S., Electrical
Engineering).
Lesley Millar
Lesley Millar, was appointed Director of the Office
of Technology Management (OTM) at the University of Illinois at Urbana-Champaign
in 2006 after serving as Interim Director for most of 2005; she originally
joined the Office in 2002 as an Engineering Technology Manager.
Prior to joining the OTM, Ms. Millar had an extensive career in government
in England where she worked in consulting, contract and small business management,
strategic planning, and policy development. Her direction during 13 years
of service as a Section Leader for Information Technology Strategy and Consulting
in the Bristol City Council resulted in an organizational turnaround with
significant improvements in operations, deliverables, and client satisfaction.
Ms. Millar also oversaw a team managing the introduction of new legislation
to the Bristol city government, and was subsequently responsible for the
award, implementation, and management of contracts across a range of service
areas.
A native of Scotland, Ms. Millar earned a bachelors degree in Education
from Dunfermline College of Physical Education
(now part of the University of Edinburgh) and came to the United States for
a masters degree in Education at the University of Georgia, Athens. While
earning her MBA at the University of Illinois at Urbana-Champaign, Ms. Millar
also served as the Executive Student Director of OSBI Consulting, where she
managed operations of the consulting arm of the MBA program.
Carla S. Mulhern
Ms. Mulhern specializes
in the application of microeconomic principles to issues arising in complex
business litigation. She has served as an expert witness in intellectual
property damages cases involving patent, copyright and trademark infringement
as well as misappropriation of trade secrets. Her intellectual property
experience spans a variety of industries including: automotive, computers,
consumer products, medical devices, pharmaceuticals and semiconductors. In
addition, she has worked with leading academic experts on numerous intellectual
property, antitrust and breach of contract cases. Ms. Mulhern is
a frequent writer and speaker on issues related to intellectual property
damages assessment. She has an M.Sc. in Economics from the London School
of Economics and Political Science and a B.S. in Mathematics from Bucknell
University.
Mike Pellon
Mike Pellon is
Vice President of Standards for Motorola and is responsible for establishing
leading positions for Motorola technology in industry alliances and standards
organizations. Mike and his team develop and execute the strategies to
place Motorola technology in leading industry standards for wireless communications,
converged services for mobile and fixed networks, consumer electronics,
automotive and industrial applications.
Before assuming
his current position in September 2002, Mike spent 5 years in Motorola’s
Messaging Business as a General Manager responsible for various businesses
in the US and Latin America. In his last assignment, he was Vice President
and General Manager of Motorola’s Wireless Messaging Division and led a
profit and loss center with over 300 employees directly responsible for
sales, marketing, product development and manufacturing.
Mike’s career
has included leadership roles in both corporate functions and business
units. He lived in the UK for 5 years and served as Vice President and
Director of Government Relations for Motorola’s headquarters in the Europe,
Middle East and Africa region. Within Motorola’s communication businesses,
he has served as product manager, led a strategic marketing team for the
land mobile systems business and held sales management positions for enterprise
accounts.
Mike received
a BA degree from Bowdoin College and a Masters
in Business Administration from Georgia State University. He serves on
the boards of the IEEE Industry Standards and Technology Organization and
the Wireless World Research Forum
Ronald A. Pepin
Dr. Ronald A. Pepin, PhD,
is Senior Vice President, Business Development at Medarex, a biopharmaceutical
company that is focused on treating human diseases with fully human monoclonal
antibodies that they generate using their proprietary UltiMab Mouse platform
technologies. He has formed alliances with Bristol-Myers Squibb, Pfizer,
Abbott, Corixa, Sangamo,
Massachusetts Biologic Laboratories and diaDexus,
among others.
Prior to joining Medarex in 2000, Dr. Pepin worked at Bristol-Myers Squibb
for ten years, where he held the position of Executive Director, External
Science and Technology and was responsible for the licensing of new technologies
and establishing research collaborations.
Dr. Pepin received his B.A. degree in biology
at Tufts University and earned his Ph.D. in genetics from Georgetown University. Dr.
Pepin was a postdoctoral research associate at the Banting and
Best Department of Medical Research at the University of Toronto as well
as in the Department of Biochemistry at Case Western Reserve University
in Cleveland, Ohio. He served as the Manager of Molecular Genetics at
Interferon Sciences, Inc., as well as setting up and directing the research
in other biotechnology companies.
Lisa
J. Pirozzolo
Ms. Pirozzolo has
a general commercial litigation practice, with particular emphasis on intellectual
property litigation. She has represented clients in patent infringement
suits involving a wide variety of technologies including lasers, integrated
circuits, recombinant proteins and liquid chromatography. She has also
represented clients in litigation and arbitration involving trademark,
contract and insurance issues. Ms. Pirozzolo received
a J.D. degree, cum laude, from Cornell Law School where she served
as editor-in-chief of the Cornell International Law Journal. She
received a B.A. in Classics from Yale College. Following law school she
clerked for the Hon. Franklin S. Billings Jr., district judge of the U.S.
District Court for the District of Vermont. Ms. Pirozzolo is
admitted to practice in the Commonwealth of Massachusetts.
Ed Rashba
Ed Rashba leads
the New Technical Programs area at the IEEE Standards Association (IEEE-SA). His
group works to initiate market-driven standards as well as those in emerging
technology areas, such as, for example, in the area of nanoelectronics.
Prior to joining
IEEE, Ed was a principal at a consulting firm which assisted holders of
proprietary technology to commercialize their innovations. He also founded
a telecommunications firm which became one of the largest service providers
in Austria.
Ed has a BA degree
from SUNY Binghamton, and an MBA from Columbia University .
Dorothy Raymond
Dorothy Raymond is in transition from senior vice president and general counsel for Cable
Television Laboratories, Inc. (CableLabs) to
part-time private practice specializing in strategic technology transactions. In
her role as general counsel for CableLabs, Dorothy
has been responsible for all legal matters involving CableLabs,
including antitrust compliance, intellectual property rights issues for CableLabs' specification efforts, protection of intellectual
property, and other general corporate and contractual matters. In addition,
Dorothy is a member of the senior staff of CableLabs,
providing input on policy and strategic issues, including CableLabs’
efforts to develop and certify interoperable high speed data modems and advanced
digital set-top boxes.
Among Dorothy’s
accomplishments while at CableLabs are establishing
royalty-free license pools for CableLabs' cable
modem and PacketCable projects, and establishing
a sub-licensing program for third party security software needed by cable
modem manufacturers. She is also responsible for monitoring the procedures
of CableLabs' various specification compliance
review boards.
Dorothy has spoken
on a wide variety of topics relating to antitrust and cable television
legal matters. Publications include the chapter “The Role Of In-House
Counsel” in Judy Whalley, ed., Merger Review
Process, (American Bar Association, 1995). She served as Adjunct Professor
for the University of Colorado School of Law, where she lectured on Intellectual
Property Law.
Before joining CableLabs,
Dorothy was a staff attorney for Tele-Communications, Inc. (TCI) responsible
for mergers and acquisitions, and then Vice President and General Counsel
for WestMarc (a TCI subsidiary) with legal responsibilities
including TCI's alternative access business and its satellite-delivered
programming business. She holds a law degree from the University of Colorado
and an undergraduate degree (summa cum laude) from the University of Denver.
CableLabs is
a research and development consortium of cable television system operators
representing the continents of North America and South America. CableLabs plans and funds research and development projects
that will help cable companies take advantage of future opportunities and
meet future challenges in the cable television industry.
It also transfers
relevant technologies to member companies and to the industry. In addition, CableLabs acts
as a clearinghouse to provide information on current and prospective technological
developments that are of interest to the cable industry. CableLabs maintains
web sites at www.cablelabs.com; www.cablemodem.com;
www.cablenet.org; www.opencable.com; and www.packetcable.com.
Peter N. Reikes
Peter N. Reikes, Global Head of Health Care Investment Banking
at Cowen & Co, LLC since
1999 following 14 years at PaineWebber. Mr. Reikes is
a former director of Biocompatibles Ltd., Trylon Corporation,
and the research and development limited partnership boards of Alkermes,
Inc., Cephalon, Inc., Gensia, Inc., Genzyme Corporation, and Repligen
Corporation. Mr. Reikes received an M.B.A. in Finance from The Wharton
School at the University of Pennsylvania and a B.A. in Economics from
the University of California at Los Angeles.
John Ritter
John Ritter has been at Princeton University
since 1996 as Director of Technology Licensing and Intellectual Property. Prior
to joining Princeton, Mr. Ritter worked at Rutgers University handling
matters relating to intellectual property and also had several sales and
marketing positions in industry. Mr. Ritter has a Bachelor of Science
in Engineering from Rutgers University, an MBA from Fairleigh Dickinson University and his law degree from Rutgers
University. A registered patent attorney, Mr. Ritter is licensed
to practice law in New Jersey, Pennsylvania, and the U.S. District Court
in New Jersey.
Karin Rivard
Karin Rivard is
the Assistant Director and Counsel of the Technology Licensing Office at
the Massachusetts Institute of Technology. She counsels members of the
office in protecting and licensing new inventions and intellectual property
for MIT, the Whitehead Institute and Lincoln Laboratory, as well as for
the MIT-hosted World Wide Web Consortium. Karin works closely with MIT’s
Office of Sponsored Programs, Office of Intellectual Property Counsel and
Office of Senior Counsel. She also manages the protection and licensing
of MIT’s trademark portfolio.
Karin has been practicing law for 12 years. Prior
to joining the MIT Technology Licensing Office in 1996, she practiced corporate
and general business law, beginning at Testa,
Hurwitz & Thibeault in 1992 and then later at a corporate boutique
firm, White & McDermott, PC. Karin has presented for AUTM, MCLE, and
the National Council of University Research Administrators (NCURA), and
has been a guest lecturer at the Franklin Pierce Law Center.
Karin received her law degree from the University
of Southern California Law School and her undergraduate degree from Brandeis
University.
Carl A. Rust
Carl A. Rust is Associate Director of the Packaging Research
Center at the Georgia Institute of Technology, which is funded by the National
Science Foundation, global industry, and the State of Georgia at approximately
$18M annually. The center focuses on research and education for next-generation
microelectronic packaging and integration technologies for communication,
computer, and consumer applications. He is responsible for industry collaboration,
technology transfer, new business development, strategic operations, and
global collaboration.
Carl is also a co-founder of three start-up
companies which have acquired a combined total of over $30M venture capital
funding and employ over 100 people. Prior to his present position he was
Executive Director of the CALCE Center at the University of Maryland and
prior to that held several engineering and management positions at Texas
Instruments. He earned a BSEE degree in 1984 from The Citadel and has
15 publications.
Jill A. Tarzian Sorensen
Jill A. Tarzian Sorensen
is the Executive Director of Johns Hopkins Technology Transfer office,
serving eight of the nine schools (not the Applied Physics Laboratory)
of Johns Hopkins University, while also providing intellectual property
and technology transfer services to Johns Hopkins International. Johns
Hopkins University manages approximately $1.5 billion in research expenditures
per year, with technology transfer servicing approximately 270 new invention
disclosures per year. Jill oversees a staff of 30, 15 of whom are corporate
relations, business development, ventures and licensing professional staff,
a portfolio of approximately 1500 active inventions and 2800 issued patents.
Throughout her twenty year career in the
education sector, Jill has promoted active interaction with research faculty,
staff and students, engaging in graduate education, internship programs,
professional development, and thought leadership. She has also worked
creatively and productively to partner university inventors with industry
champions to advance innovation and knowledge transfer. Previous to joining
Johns Hopkins University on March 1, 2005, Jill served as the Director
of the University of Illinois at Chicago Office of Technology Management
where she was responsible for technology commercialization, portfolio management,
licensing and equity deals, intellectual property assessment and valuation. Prior
to her assuming the Directorship of UIC’s intellectual
property office in September of 1998, she served as in-house intellectual
property counsel to the University of Illinois for twelve years.
Jill earned her J.D. from DePaul
University, her B.A. from Northwestern University, pursued graduate studies
in chemistry at the University of Illinois, and was a visiting scholar
to Oxford University for one year preceding her Johns Hopkins Directorship. She
has served as a panel and sole arbitrator in commercial disputes for the
past sixteen years, is a registered patent attorney in the United States,
and is registered to practice law in Illinois and in the federal 7th circuit
district court . She has been a course instructor, guest lecturer, and
presenter on many topics related to intellectual property and research,
and authored numerous intellectual property and technology transfer instructional
works, including co-authoring a second edition to an AUTM educational guide
on patent law.
Gina Stewart
Gina Stewart joined Seed Stage Associates in 2003,
where her focus has been on university technology transfer consulting and
early stage technology commercialization. Stewart also runs Sage Technology
Management, Inc., and has been president of Sage since 2001.
Gina led a joint UNC-Chapel Hill and North Carolina
State University patent donation initiative from 2000 until 2003. Prior
to joining UNC, Gina served as director of laboratories and operations
for a university start-up company.
Gina conducted post-doctoral research on polymer
synthesis in carbon dioxide in the research group of Joseph DeSimone. She
earned a Ph.D. in organic chemistry from the University of Texas where
her research on photochemistry of artificial photosynthesis systems was
conducted in the laboratories of Marye Anne Fox.
Gina is an inventor on seven US patents. She earned
a bachelors degree with honors from UNC-Chapel Hill, where she was a national
merit scholar and was inducted into Phi Beta Kappa. She is a member of
the Association of University Technology Managers and the American Chemical
Society.
Erica A Sullivan
Erica Sullivan has been in business development
for the past three years with the Technology Transfer Division at Los Alamos
National Laboratory. Erica works with the biosciences commercialization
team to identify commercialization opportunities for LANL’s biological
technologies. She also provides marketing support for this team. In addition
to business development, Erica runs a number of educational programs for
the Tech Transfer division. She has
implemented several student programs to introduce LANL students to technology
transfer and works with professors at New Mexico State University and San
Diego State University to create graduate level courses in technology commercialization.
Erica received a BA in Economics and BA in
Biology from Loyola Marymount University and
an MBA from San Diego State University.
Shirley Ann Vanier
Shirley Ann Vanier is the Business Development Officer for the National Functional Genomics Center (NFGC)
at the H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa,
FL. (Moffitt). The NFGC is funded through the U.S. Department
of Defense through the passage of Public Law 107-117. The Center’s mission in broad terms is to identify
and validate molecular signatures/profiles and targets for the many forms
of cancer and to provide solution based technologies that enable personalized
medicine to become the standard of care. As the Business Officer, Shirley’s
role is to ensure that the business office is the first line of defense
in regards to maintaining and developing the relationships resulting from
the NFGC’s Consortium.
Shirley has also served as Director, Office
of Technology Management and Commercialization at Moffitt. She
established the technology transfer office. Developed systems, processes,
and policies and procedures related to the effective functioning of the
office, including the purchase and licensing of databases and budgetary
responsibilities. Trained staff. Drafted and negotiated many levels of
agreements. Prior to her tenure at Moffitt Shirley was the Sr. Licensing
Associate at Emory University in Atlanta, GA.
For more than 16 years she was Intellectual
Property and in-house Counsel in Industry. She negotiated several types
of agreements drafted and prosecuted patent application with review and
signature from Patent Counsel and managed an extensive patent portfolio
for a billion dollar multi-national company.
Mark C. Wiggins
Mark C. Wiggins is Executive Vice President,
Business Development at Biogen-Idec.
Before the merger with Idec, Mark held various
positions in Business Development and Marketing at Biogen since
joining the company in 1998. From 1986 to 1996 he held various positions
at Schering-Plough, including Director of Business Development and from
1996 to 1998 he was Vice President of Business Development and Marketing
for Hybridon. Mr Wiggins spent 15 years with Pfizer, J
and J and Schering Plough.
Mr. Wiggins received a B.S. from Syracuse
University in finance and received his M.B.A from the University of Arizona.
Christopher F. Wright
A shareholder of McCausland, Keen & Buckman in
Radnor, PA, Mr. Wright is a transactional attorney handling all aspects
of entrepreneurial endeavors with an emphasis on business and intellectual
property law. He focuses his practice on growth technology companies,
equity investors, and universities and research institutions that license
technology. Mr. Wright recently served as Associate General Counsel for
the University of Pennsylvania and Director of Legal Affairs for Penn's
Center for Technology Transfer. Prior to joining the Firm, Mr. Wright
served as Senior Vice President & General Counsel of EXE Technologies,
Inc., a publicly-traded, global provider of supply chain execution software
and services. Before joining EXE, Mr. Wright was a partner in the Berwyn,
PA office of Pepper Hamilton LLP. Mr.
Wright graduated from Brown University with an A.B. in Applied Mathematics
and Economics. He received his J.D. from the Law School of the University
of Pennsylvania, where he was an editor of the Law Review.
Taro Yaguchi
Mr. Yaguchi is the former Chairman
of the Patent Committee of the Japan Patent Attorneys Association and an
Advisor to the Patent Committee of the Software Information Center (SOFTIC).
He specializes in the fields of mechatronics,
semiconductor manufacturing technology, computer software and Bioinformatics.
He is a co-author of Practice for American Patents by the Japan
Institute of Invention and Innovation on February 2000, Illustrated
Instruction to Business Method Patents and The Latest U.S. Business
Method Patents 564 published by Jitstugyo no
Nihon-sha, Ltd., 2001. He is currently a senior
partner at Omori & Yaguchi, Tokyo, Japan
as well as a president of Omori & Yaguchi USA,
Philadelphia, PA.
James R. Zanewicz
James R. Zanewicz,
J.D., LL.M., started the Office of Technology Development at
the University of Louisville in December of 2000, and guided the office’s
development and growth into the Office of Technology Transfer. He
is originally from Kentucky, where he earned a B.S. in Chemistry from
Centre College. On his winding path around the U.S. and back to the Bluegrass
State, he has lived in: New Orleans where he earned his J.D. from Tulane
Law School, New Jersey while he was working as a chemist and a patent
law clerk for Rhone-Poulenc, Los Angeles where he handled internet, multimedia,
production and intellectual property issues for the Warner Bros. daily
syndicated news-magazine EXTRA, and Urbana-Champaign, Illinois, where
he first entered the exciting realm of University Technology Transfer
and learned much of what he knows from Ann Hammersla and
Jill Tarzian Sorensen.
James is admitted to practice before both
the Kentucky Bar and the U.S. Patent and Trademark Office, and authored
a thesis on "Online Data Privacy in the United States: Analysis and
Proposed Regulatory Scheme" as part of earning his LL.M. in Intellectual
Property and Media Issues from the University of Illinois at Urbana-Champaign. He
co-chairs the Licensing and Technology Transfer Committee for BIO, is a
steering committee member of OVALS (The Ohio Valley Affiliates for Life
Sciences), has served on several AUTM committees, and is an active member
of COGR. His proudest achievement is his involvement as a disaster services
volunteer for the American Red Cross.
John S. Zawad
Dr. Zawad is Managing
Director of Intellectual Property & Technology Transfer at the University
of Pennsylvania where he is responsible for the commercialization of Penn
inventions. He has over 20 years experience in the pharmaceutical industry
in sales/marketing, competitive intelligence, product development, business
development and equity management. Prior to joining UPenn he
was Vice President of Aventis Capital, the strategic
investment arm of Aventis Inc., where he was
involved in the management of equity holdings and venture fund investments.
These included over 50 public and private portfolio companies and over
$500 million under management. He formerly was Vice President of Technology
Licensing & Alliances within the Corporate Development group at Aventis
Pharma. Dr. Zawad received his Ph.D. in biochemistry from the University
of Tennessee Center for the Health Sciences.
Daphne Zohar
Ms. Daphne Zohar is the Founder and Managing Partner
of PureTech Ventures, a Boston-based life sciences venture firm focused on
creating leading companies based on academic innovation. Daphne Zohar was
named one of the world's top young innovators by MIT's Technology Review
Magazine and one of the top "40 under 40" by the Boston Business
Journal. She sits on the boards of Neovasc Medical,
Solace Inc., Follica Inc., Enlight Biosciences
and Satori Pharmaceuticals and is a member of
the Board of Associates of the Whitehead Institute.
|
